Associations of complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) genotypes with subtypes of polypoidal choroidal vasculopathy.
暂无分享,去创建一个
Yoshihiro Mizutani | Akiyuki Kawamura | Tomohiro Nakayama | T. Nakayama | N. Sato | Y. Mizutani | M. Yuzawa | R. Mori | Ryusaburo Mori | Mitsuko Yuzawa | Naoyuki Sato | Koji Tanaka | Koji Tanaka | A. Kawamura
[1] A. Okubo,et al. Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.
[2] T. Nakayama,et al. Novel mutations of ABCC6 gene in Japanese patients with Angioid streaks. , 2009, Biochemical and biophysical research communications.
[3] Akira Negi,et al. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. , 2007, American journal of ophthalmology.
[4] E. Boerwinkle,et al. Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. , 2008, American journal of hypertension.
[5] R. Yamada,et al. ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. , 2009, American journal of ophthalmology.
[6] Hiroyuki Shimada,et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.
[7] A. Thalamuthu,et al. Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.
[8] K. Choy,et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. , 2006, American journal of ophthalmology.
[9] A. Negi,et al. Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. , 2009, Ophthalmology.
[10] Y. Miyake,et al. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation , 2002, The British journal of ophthalmology.
[11] M. Matsumura,et al. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.
[12] K. Matsuo,et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. , 2010, Investigative ophthalmology & visual science.
[13] J. Slakter,et al. INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY , 1995, Retina.
[14] M. Yuzawa,et al. The origins of polypoidal choroidal vasculopathy , 2005, British Journal of Ophthalmology.
[15] M. Yuzawa,et al. Correlation Between Indocyanine Green Angiographic Findings and Histopathology of Polypoidal Choroidal Vasculopathy , 2004, Japanese Journal of Ophthalmology.
[16] Kanji Takahashi,et al. [Classification and diagnostic criteria of age-related macular degeneration]. , 2008, Nippon Ganka Gakkai zasshi.
[17] H. Iijima,et al. Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy. , 2011, Ophthalmology.